Tirzepatide: A Novel Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide 1 Receptor Agonist for the Treatment of Type 2 Diabetes: The First Twincretin: Clinical Diabetes
- A.V. Fanshier
- , B.K. Crews
- , M.C. Garrett
- , J.L. Johnson
Research output: Contribution to journal › Article › peer-review
13
Link opens in a new tab
Scopus
citations